FE
EpiEndo Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| glasmacinal (EP395) | COPD (Chronic Obstructive Pulmonary Disease) | Phase 1 |
Leadership Team at EpiEndo Pharmaceuticals
MB
Maria Bech, MSc
Chief Executive Officer
SP
Stefán Pétursson, Cando econ
Chief Financial Officer
GN
Ginny Norris, MRCP
Chief Medical Officer
JK
Jennifer Kricker, PhD
Head of Research
HB
Hilmar Bragi Janusson, PhD
Chairman of the Board